Amgen (AMGN) Dividends Paid - Common (2011 - 2026)

Amgen (AMGN) posted quarterly Dividends Paid - Common of $1.4 billion for Q1 2026, up 6.18% year-over-year from $1.3 billion in Q1 2025, and up 5.85% on a QoQ basis from $1.3 billion in Q4 2025.

Amgen (AMGN) Dividends Paid - Common (2011 - 2026) Analysis & Trends

Amgen (AMGN) has reported Dividends Paid - Common for 16 consecutive years, with $1.4 billion the latest figure, recorded in Q1 2026.

  • In Q1 2026, Dividends Paid - Common rose 6.18% year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $5.2 billion (up 6.12% YoY), while the FY2025 annual figure was $5.1 billion, up 6.04% from the prior year.
  • Dividends Paid - Common came in at $1.4 billion for Q1 2026 at Amgen, up from $1.3 billion in the prior quarter.
  • The five-year high for Dividends Paid - Common was $1.4 billion in Q1 2026, with the low at $1.0 billion in Q2 2022.
  • Average Dividends Paid - Common over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2024.
  • Across the five-year window, Dividends Paid - Common grew 2.98% in 2022 and grew 9.83% in 2023, its largest moves.
  • Year by year, Dividends Paid - Common stood at $1.0 billion in 2022, then gained by 9.62% to $1.1 billion in 2023, then advanced by 5.7% to $1.2 billion in 2024, then grew by 6.47% to $1.3 billion in 2025, then advanced by 5.85% to $1.4 billion in 2026.
  • According to Business Quant data, Dividends Paid - Common over the past three periods registered $1.4 billion, $1.3 billion, and $1.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 1.55 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 3.13 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 3.09 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -3.29 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 2.11 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 1.36 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 1.04 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 2.45 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.36 Bn
Mar 31, 2026 1.36 Bn
Dec 31, 2025 1.28 Bn
Dec 31, 2025 1.28 Bn
Sep 30, 2025 1.28 Bn
Sep 30, 2025 1.28 Bn
Jun 30, 2025 1.28 Bn
Jun 30, 2025 1.28 Bn
Mar 31, 2025 1.28 Bn
Mar 31, 2025 1.28 Bn
Dec 31, 2024 1.21 Bn
Dec 31, 2024 1.21 Bn
Sep 30, 2024 1.21 Bn
Sep 30, 2024 1.21 Bn
Jun 30, 2024 1.21 Bn
Jun 30, 2024 1.21 Bn
Mar 31, 2024 1.21 Bn
Mar 31, 2024 1.21 Bn
Dec 31, 2023 1.14 Bn
Dec 31, 2023 1.14 Bn